Liver/Gut Inflammation and Fibrosis Research Group
About the Liver/Gut Inflammation and Fibrosis Research Group
Liver fibrosis and cirrhosis is the common end stage to all liver diseases in humans. We study mechanisms of liver fibrosis and factors that determine its progression to cirrhosis.
The Liver/Gut Inflammation and Fibrosis Research Group has been continuously active over ten years and regularly contributes to international trials of new antiviral agents for hepatitis B and C in addition to developing and leading national investigator-initiated studies.
Professor William Sievert
Professor Sievert has a long-term interest in liver disease and directs an active clinical research unit comprising physician-scientists, clinical research nurses and research students. He also directs a basic research laboratory investigating mechanisms of inflammatory liver injury and hepatic fibrogenesis, with a translational focus on identification and development of potential hepatic antifibrotic agents.
Meet the people making waves in Liver/Gut Inflammation and Fibrosis Research.
Read and access our key publications.